Dentists in Columbus, WI Accepting Medicare
6 Dentists found. Showing 1 - 6
 Dr. James Michael Beck, DDS Dentist Medicare: Medicare Enrolled Practice Location: 1505 Park Ave., Columbus, WI 53925 Phone: 920-623-2340 Fax: 920-623-2765 |
Dr. William James Becker, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1505 Park Ave., Columbus, WI 53925 Phone: 920-623-2340 Fax: 920-623-2765 |
Dr. Adam L Forster, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1132 Park Ave, Columbus, WI 53925 Phone: 920-623-5559 Fax: 920-623-0127 |
 Dr. Kelly Marie Servais, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1501 Park Ave, Columbus, WI 53925 Phone: 920-623-5559 |
Dr. Matthew Richard Clary, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1132 Park Ave, Columbus, WI 53925 Phone: 920-623-5559 Fax: 920-623-0127 |
Dr. Andrew Nothem, D.D.S. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 1501 Park Ave, Columbus, WI 53925 Phone: 920-623-5559 |
News Archive
Virtual screening tool simplifies the process of diagnosing pulmonary hypertension
The COVID-19 pandemic has increasing numbers of doctors caring for patients virtually. While critical to protecting patient health during a pandemic, however, virtual care presents unique challenges, especially when it comes to diagnosis.
Everolimus-eluting stent and SES are equally effective for PCI patients
The second generation drug-eluting stent, everolimus-eluting stent (EES), has consistently demonstrated superior clinical outcomes in randomised controlled trials over the first generation drug-eluting stent, paclitaxel-eluting stent.
Guidelines and best practices to provide care for seniors during COVID-19 pandemic
Older adults are at elevated risk for complications from COVID-19 and are dying at a higher rate than younger patients.
Scientists identify biological pathways that mediate IgA nephropathy
For the first time, researchers have found five regions in the human genome that increase susceptibility to immunoglobulin A nephropathy, a major cause of kidney failure worldwide - systematically identifying those that point to a tendency for IgA nephropathy, or a protection against it.
Biocon, Pfizer enter global agreement to commercialize Insulin analog products
Biocon, Asia's premier biotechnology company, and Pfizer Inc. (NYSE: PFE), the world's leading biopharmaceutical company, today announced that they have entered into a strategic global agreement for the worldwide commercialization of Biocon's biosimilar versions of Insulin and Insulin analog products: Recombinant Human Insulin, Glargine, Aspart and Lispro.
› Verified 8 days ago
Pharmacists
Dentists
Occupational Therapists
Clinical Social Workers